• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

托斯卡纳地区罕见病网络:从欧洲参考网络的经验到基于登记的罕见病组织和管理模式。

The Tuscany Regional Network for rare diseases: from European Reference Networks' experience to registry based organisation and management model for rare diseases.

机构信息

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

出版信息

Orphanet J Rare Dis. 2023 Oct 13;18(1):324. doi: 10.1186/s13023-023-02947-4.

DOI:10.1186/s13023-023-02947-4
PMID:37833795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10576286/
Abstract

BACKGROUND

In the European Union, a disease is defined as rare when it affects fewer than 1 in 2000 people. Currently, there are up to 8000 described rare diseases (RDs), collectively affecting 30 million people in the European Union. In 2004 Tuscany region (Italy) established a Regional Network of hospital units to ensure highly specialised medical care in the field of RDs. Shortly after the Rare Diseases Registry of Tuscany (Registro Toscano Malattie Rare-RTMR) was implemented. Here we describe the analysis performed on RTMR data which has recently allowed to remap the Network based on European Reference Networks' model.

RESULTS

Data analysis was performed on 60,367 cases registered in RTMR, regarding 628 RDs. Two-hundred and fifteen active presidia have been evaluated. The assignment of each RD to the suitable European Reference Network has been made considering not only the number of registered cases, certifications and treatment plans for each Regional Presidium but also the competence in multidisciplinary management of the patient, from diagnosis to treatment. This evaluation has led to the establishment of twenty-one Regional Coordination Centres. They aggregate and coordinate Hospital Units which diagnose and treat one or a group of related RDs. In case of wide groups of RDs, Clinical Subnets are instituted. Updated statistics regarding RDs in Tuscany, list of RDs and Coordination Centres, as well as information about single Presidia are published and freely available on a designated webpage. Regional Decrees are regularly updated according to the network evolution.

CONCLUSIONS

The Rare Diseases Regional Network in Tuscany, based on the ERN model, has played a pivotal role in enhancing RD management and research. The remapping has led to a dynamic system, following not only scientific research but also the development of Presidia's expertise. By pooling resources and expertise, the network has improved the availability and accessibility of specialized care for patients with RDs. Collaborative efforts, data sharing, and standardized registries are crucial for advancing RD research, improving diagnosis and treatment, and ultimately enhancing the quality of life for individuals living with RDs.

摘要

背景

在欧盟,当一种疾病影响每 2000 人中少于 1 人时,就被定义为罕见病。目前,有多达 8000 种已描述的罕见病(RDs),共同影响着欧盟的 3000 万人。2004 年,托斯卡纳地区(意大利)建立了一个医院单位区域网络,以确保在罕见病领域提供高度专业化的医疗护理。此后不久,托斯卡纳罕见病登记处(Registro Toscano Malattie Rare-RTMR)也随之建立。在这里,我们描述了最近基于欧洲参考网络模型对 RTMR 数据进行的分析。

结果

对 RTMR 中登记的 60367 例、628 种 RD 病例进行了数据分析。评估了 215 个活跃的presidia。考虑到每个区域presidium 的登记病例数、认证和治疗计划,以及从诊断到治疗的患者多学科管理能力,为每个 RD 分配到合适的欧洲参考网络。这种评估导致了 21 个区域协调中心的建立。它们聚合和协调诊断和治疗一种或一组相关 RD 的医院单位。在广泛的 RD 组的情况下,设立了临床子网。关于托斯卡纳 RD 的最新统计数据、RD 列表和协调中心,以及关于单个 presidia 的信息,都在指定的网页上发布并免费提供。区域法令根据网络的发展定期更新。

结论

托斯卡纳罕见病区域网络基于 ERN 模型,在加强 RD 管理和研究方面发挥了关键作用。重新映射不仅遵循科学研究,还遵循 presidia 专业知识的发展,导致了一个动态系统。通过汇集资源和专业知识,该网络提高了 RD 患者获得专门护理的可及性和可及性。协作努力、数据共享和标准化登记对于推进 RD 研究、改善诊断和治疗、最终提高 RD 患者的生活质量至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/ed2215b7203e/13023_2023_2947_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/11a6f2c5f82c/13023_2023_2947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/30cd53f696d7/13023_2023_2947_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/f35c688354c8/13023_2023_2947_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/393fc03fbba9/13023_2023_2947_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/ed2215b7203e/13023_2023_2947_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/11a6f2c5f82c/13023_2023_2947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/30cd53f696d7/13023_2023_2947_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/f35c688354c8/13023_2023_2947_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/393fc03fbba9/13023_2023_2947_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1663/10576286/ed2215b7203e/13023_2023_2947_Fig5_HTML.jpg

相似文献

1
The Tuscany Regional Network for rare diseases: from European Reference Networks' experience to registry based organisation and management model for rare diseases.托斯卡纳地区罕见病网络:从欧洲参考网络的经验到基于登记的罕见病组织和管理模式。
Orphanet J Rare Dis. 2023 Oct 13;18(1):324. doi: 10.1186/s13023-023-02947-4.
2
The pooling of manpower and resources through the establishment of European reference networks and rare disease patient registries is a necessary area of collaboration for rare renal disorders.通过建立欧洲参考网络和罕见病患者登记处来集中人力和资源,是罕见肾脏疾病必要的合作领域。
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv9-14. doi: 10.1093/ndt/gfu094.
3
Rare Diseases in Europe: from a Wide to a Local Perspective.欧洲的罕见病:从宏观到局部视角
Isr Med Assoc J. 2016 Jun;18(6):359-63.
4
Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network.提高罕见病诊断水平:意大利未确诊罕见病网络的经验。
Ital J Pediatr. 2020 Sep 14;46(1):130. doi: 10.1186/s13052-020-00883-8.
5
[Healthcare networks for people with rare diseases: integrating data and expertise].[面向罕见病患者的医疗保健网络:整合数据与专业知识]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022 Nov;65(11):1164-1169. doi: 10.1007/s00103-022-03592-1. Epub 2022 Sep 27.
6
ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions.ERN BOND:利用诊断、研究和治疗罕见骨骼疾病的关键欧洲网络。
Eur J Med Genet. 2024 Apr;68:104916. doi: 10.1016/j.ejmg.2024.104916. Epub 2024 Feb 1.
7
Healthcare Burden of Rare Diseases: A Population-Based Study in Tuscany (Italy).罕见病的医疗负担:托斯卡纳(意大利)的一项基于人群的研究。
Int J Environ Res Public Health. 2022 Jun 21;19(13):7553. doi: 10.3390/ijerph19137553.
8
Survival of patients with rare diseases: a population-based study in Tuscany (Italy).罕见病患者的生存状况:意大利托斯卡纳地区的一项基于人群的研究。
Orphanet J Rare Dis. 2021 Jun 14;16(1):275. doi: 10.1186/s13023-021-01907-0.
9
The European Reference Network for Rare Neurological Diseases.欧洲罕见神经系统疾病参考网络。
Front Neurol. 2021 Jan 14;11:616569. doi: 10.3389/fneur.2020.616569. eCollection 2020.
10
Profile of Drug Utilization in Patients with Rare Diseases in Tuscany, Italy: A Population-Based Study.意大利托斯卡纳地区罕见病患者药物利用情况分析:一项基于人群的研究。
Int J Environ Res Public Health. 2023 Jan 4;20(2):937. doi: 10.3390/ijerph20020937.

引用本文的文献

1
The B-cells paradigm in systemic sclerosis: an update on pathophysiology and B-cell-targeted therapies.系统性硬化症中的B细胞范式:病理生理学及B细胞靶向治疗的最新进展
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae098.

本文引用的文献

1
Diagnostic delay in rare diseases: data from the Spanish rare diseases patient registry.罕见病诊断延迟:来自西班牙罕见病患者登记处的数据。
Orphanet J Rare Dis. 2022 Nov 17;17(1):418. doi: 10.1186/s13023-022-02530-3.
2
Rare disease emerging as a global public health priority.罕见病成为全球公共卫生重点关注对象。
Front Public Health. 2022 Oct 18;10:1028545. doi: 10.3389/fpubh.2022.1028545. eCollection 2022.
3
Inflammatory muscle disease - An update.炎性肌病——最新进展。
Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101484. doi: 10.1016/j.berh.2019.101484. Epub 2020 Feb 8.
4
How many rare diseases are there?有多少种罕见病?
Nat Rev Drug Discov. 2020 Feb;19(2):77-78. doi: 10.1038/d41573-019-00180-y.
5
The burden of rare diseases.罕见病的负担。
Am J Med Genet A. 2019 Jun;179(6):885-892. doi: 10.1002/ajmg.a.61124. Epub 2019 Mar 18.
6
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、地区和国家残疾调整生命年(DALYs)359 种疾病和伤害以及 195 个国家和地区 1990-2017 年的健康期望寿命(HALE):2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3.
7
Paediatric genomics: diagnosing rare disease in children.儿科基因组学:诊断儿童罕见病。
Nat Rev Genet. 2018 May;19(5):253-268. doi: 10.1038/nrg.2017.116. Epub 2018 Feb 5.
8
Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.罕见病:基于可靠的流行病学数据,融入主流研究和治疗。
Adv Exp Med Biol. 2017;1031:3-21. doi: 10.1007/978-3-319-67144-4_1.
9
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.患有罕见疾病的澳大利亚儿童:诊断经历及诊断延迟的感知后果
Orphanet J Rare Dis. 2017 Apr 11;12(1):68. doi: 10.1186/s13023-017-0622-4.
10
Survey of healthcare experiences of Australian adults living with rare diseases.澳大利亚成年罕见病患者医疗保健经历调查。
Orphanet J Rare Dis. 2016 Mar 24;11:30. doi: 10.1186/s13023-016-0409-z.